Healthcare
Live Price
Offline$0.21
-4.55% today
1Y Change
+16.67%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Perimeter Medical Imaging AI, Inc. (PYNKF) is a Healthcare stock with a market cap of $30.00M and listed on OTC. The stock last traded around $0.21 and up 16.7% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +177.0%, EPS growth of +15.8%, a dividend yield of 0.0%. What stands out right now is revenue +177.0%, EPS +15.8%, free cash flow +43.5% with operating margin -555.9% and ROIC -299.5%. Valuation already assumes a fairly strong business story at price/sales 10.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PYNKF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PYNKF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PYNKF Max Drawdown
-53.33%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PYNKF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
-100.0% YoY
FY Net Income
-$8.0M
+52.3% YoY
Free Cash Flow
-$8.3M
+48.5% YoY
Revenue Growth
+177.0%
EPS Growth
+15.8%
Gross Margin
52.4%
Net Margin
-554.9%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 846K | 404K | 133K | 11K | 0 |
| Gross Profit | 535K | 206K | 101K | 5K | -48K |
| Operating Income | -19M | -16M | -16M | -16M | -12M |
| EBITDA | -13M | -13M | -12M | -16M | -6M |
| Net Income | -13M | -19M | -4M | -17M | -8M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 6M | 14M | 28M | 5M | 10M |
| Total Assets | 14M | 21M | 35M | 10M | 13M |
| Total Liabilities | 4M | 5M | 8M | 3M | 2M |
| Shareholder Equity | 10M | 15M | 26M | 7M | 11M |
| Total Debt | 137K | 193K | 326K | 441K | 401K |
| Net Debt | -6M | -14M | -28M | -4M | -10M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
8M
+40.6% YoY
Capital Expenditures
0
+100.0% YoY
Free Cash Flow
8M
+48.5% YoY
Key ratios
Gross Margin
52.4%
Operating Margin
-555.9%
Net Margin
-554.9%
ROE
-258.6%
Debt / Equity
0.03x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.